Governance Duncan Maskell MA, PhD, FMedSci, Hon Assoc RSVC Age 63 Independent Non-executive Director Director of CSL Limited since August 2021. Marie McDonald BSc (Hons), LLB (Hons) Age 68 Independent Non-executive Director Director of CSL Limited since August 2013. Alison Watkins AM BCom Age 61 Independent Non-executive Director Director of CSL Limited effective from August 2021. Professor Maskell has wide-ranging international experience in science and commerce, with a particular focus in research, academia and entrepreneurship. Professor Maskell is the Vice-Chancellor of the University of Melbourne. Prior to this he was Senior Pro-Vice-Chancellor at the University of Cambridge in the United Kingdom and has also held roles at the University of Oxford, Imperial College London and Wellcome Biotech. Professor Maskell has extensive experience across the private sector, reflecting his passion for the commercialisation of research initiatives. He has co-founded several biotech companies, including Arrow Therapeutics, which was sold to biopharmaceutical company AstraZeneca, and Discuva, which was sold to Summit Therapeutics. He has also served as a Non-Executive Director of Genus Plc, a FTSE 250 company. Professor Maskell holds a Master of Arts and a Doctor of Philosophy from the University of Cambridge. Other directorships and offices (current and recent): • Director of The Walter and Eliza Hall Institute of Medical Research (since March 2023); • Vice-Chancellor of the University of Melbourne (since October 2018); • Director of Melbourne Business School (since October 2018); • Director of the Group of Eight Limited (since October 2018); • Former Director of Universities Australia Limited (from October 2018 to June 2023); and • Former Director of the Grattan Institute (from November 2018 to August 2023). Board Committee memberships: • Member of the Innovation and Development Committee. Ms McDonald has significant executive and non-executive experience in a number of sectors including law, medical research, manufacturing and chemicals. Through these roles, Ms McDonald brings experience and insight on financial markets, risk and compliance and change management. Ms McDonald is a former lawyer with over 30 years’ experience in the legal sector. She was previously a Partner of Ashurst, specialising in mergers and acquisitions and corporate governance. She held the role of National Head of Mergers and Acquisitions and was Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia and a member of the Australian Takeovers Panel for nine years. Other directorships and offices (current and recent): • Member of the Law Committee of the AICD (since March 2023); • Member of Melbourne University Law School Foundation Board (since October 2021); • Director of Nufarm Limited (since March 2017); • Director of The Walter and Eliza Hall Institute of Medical Research (since October 2016); and • Director of Nanosonics Limited (since October 2016). Board Committee memberships: • Member of the Audit and Risk Management Committee; and • Member of the Human Resources and Remuneration Committee. Ms Watkins brings deep experience to CSL’s Board through the executive and non‑executive roles she has held across industries, including manufacturing, agriculture, consumer goods, retail and financial services. Ms Watkins was most recently the group Managing Director of ASX-listed Coca-Cola Amatil Limited, where she was responsible for operations in Australia, New Zealand, Indonesia and across the South Pacific region. Ms Watkins holds a Bachelor of Commerce from the University of Tasmania, is a fellow of the Institute of Chartered Accountants, the Financial Services Institute of Australasia, and the Australian Institute of Company Directors. Other directorships and offices (current and recent): • Director PGA of Australia (since December 2022); • Director Geoff Ogilvy Foundation (since September 2022); • Director Wesfarmers Limited (since September 2021); • Chancellor of the University of Tasmania (since July 2021); • Member of the Reserve Bank Board (since Dec 2020); and • Former Director of Centre for Independent Studies (rom December 2011 to June 2024). Board Committee memberships: • Chair of the Audit and Risk Management Committee; and • Member of the Human Resources and Remuneration Committee. Board of Directors 60 Limited Annual Report 2023/24
RkJQdWJsaXNoZXIy MjE2NDg3